{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:55:27Z","timestamp":1788299727677,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jpba.2024.116541","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T18:34:06Z","timestamp":1729622046000},"page":"116541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Effect of rapamycin on hepatic metabolomics of non-alcoholic fatty liver rats based on non-targeted platform"],"prefix":"10.1016","volume":"253","author":[{"given":"Baiyun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116541_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.jpba.2024.116541_bib2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.18632\/oncotarget.28410","article-title":"Cancer prevention with rapamycin","volume":"14","author":"Blagosklonny","year":"2023","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpba.2024.116541_bib3","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jpedsurg.2022.02.032","article-title":"Rapamycin induces autophagy and apoptosis in Kaposiform hemangioendothelioma primary cells in vitro","volume":"57","author":"Wang","year":"2022","journal-title":"J. Pedia Surg."},{"key":"10.1016\/j.jpba.2024.116541_bib4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/10408347.2020.1839737","article-title":"Bioproperties, Nanostructured System and Analytical and Bioanalytical Methods for Determination of Rapamycin: A Review","volume":"52","author":"Dos Santos","year":"2022","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116541_bib5","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1440-1746.2009.05866.x","article-title":"Rapamycin prevents concanavalin A-induced liver injury by inhibiting lymphocyte activation","volume":"24","author":"Zhang","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jpba.2024.116541_bib6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejphar.2015.11.012","article-title":"Protective role of autophagy in methionine-choline deficient diet-induced advanced nonalcoholic steatohepatitis in mice","volume":"770","author":"Chen","year":"2016","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.jpba.2024.116541_bib7","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.transproceed.2006.06.008","article-title":"Comparison of rapamycin versus FK506 on expression of cytoprotective genes in the rat kidney allografts undergoing chronic allograft nephropathy","volume":"38","author":"Teng","year":"2006","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.jpba.2024.116541_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines7030072","article-title":"Antihyperlipidemic and Antioxidant Effects of Averrhoa carambola Extract in High-Fat Diet-Fed Rats","volume":"7","author":"Aladaileh","year":"2019","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpba.2024.116541_bib9","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/ijc.32042","article-title":"Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)","volume":"144","author":"Vernieri","year":"2019","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.jpba.2024.116541_bib10","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/s41556-023-01198-6","article-title":"Malonyl-CoA is a conserved endogenous ATP-competitive mTORC1 inhibitor","volume":"25","author":"Nicastro","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jpba.2024.116541_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107806","article-title":"mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis","volume":"31","author":"Triki","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.jpba.2024.116541_bib12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.tem.2016.06.003","article-title":"Regulation and Functions of Autophagic Lipolysis","volume":"27","author":"Cingolani","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jpba.2024.116541_bib13","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.2147\/IJN.S410653","article-title":"Effective Attenuation of Arteriosclerosis Following Lymphatic-Targeted Delivery of Hyaluronic Acid-Decorated Rapamycin Liposomes","volume":"18","author":"Liu","year":"2023","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.jpba.2024.116541_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2022.102385","article-title":"Dehydroepiandrosterone alleviates oleic acid-induced lipid metabolism disorders through activation of AMPK-mTOR signal pathway in primary chicken hepatocytes","volume":"102","author":"Yao","year":"2023","journal-title":"Poult. Sci."},{"key":"10.1016\/j.jpba.2024.116541_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bbrc.2021.07.060","article-title":"Rapamycin prevents heterotopic ossification by inhibiting the mTOR pathway and oxidative stress","volume":"573","author":"Hu","year":"2021","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.jpba.2024.116541_bib16","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s10620-013-2648-3","article-title":"Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes","volume":"58","author":"Messner","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jpba.2024.116541_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/JIR.S232009","article-title":"Mitochondrial Dynamic Dysfunction as a Main Triggering Factor for Inflammation Associated Chronic Non-Communicable Diseases","volume":"13","author":"Geto","year":"2020","journal-title":"J. Inflamm. Res"},{"key":"10.1016\/j.jpba.2024.116541_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12986-017-0213-3","article-title":"Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial","volume":"14","author":"Papandreou","year":"2017","journal-title":"Nutr. Metab. (Lond. )"},{"key":"10.1016\/j.jpba.2024.116541_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11306-020-01756-1","article-title":"Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis","volume":"17","author":"Masarone","year":"2021","journal-title":"Metabolomics"},{"key":"10.1016\/j.jpba.2024.116541_bib20","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jpba.2024.116541_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MPG.0000000000002010","article-title":"Bile Acids and the Gut Microbiome as Potential Targets for NAFLD Treatment","volume":"67","author":"Zhu","year":"2018","journal-title":"J. Pedia Gastroenterol. Nutr."},{"key":"10.1016\/j.jpba.2024.116541_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111358","article-title":"Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression","volume":"8","author":"Gottlieb","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jpba.2024.116541_bib23","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease","volume":"152","author":"Chavez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jpba.2024.116541_bib24","doi-asserted-by":"crossref","first-page":"11253","DOI":"10.1021\/acs.joc.2c02096","article-title":"Concise Synthesis of Glycerophospholipids","volume":"88","author":"Mukhopadhyay","year":"2023","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jpba.2024.116541_bib25","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202154532","article-title":"Metabolic routing maintains the unique fatty acid composition of phosphoinositides","volume":"23","author":"Kim","year":"2022","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jpba.2024.116541_bib26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/BF02537479","article-title":"Structural importance of the cis-5 ethylenic bond in the endogenous desaturation product of dietary elaidic acid, cis-5,trans-9 18:2 acid, for the acylation of rat mitochondria phosphatidylinositol","volume":"30","author":"Wolff","year":"1995","journal-title":"Lipids"},{"key":"10.1016\/j.jpba.2024.116541_bib27","article-title":"Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy","volume":"10","author":"Arroyave-Ospina","year":"2021","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.jpba.2024.116541_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1104725","article-title":"Lipid droplets and polyunsaturated fatty acid trafficking: Balancing life and death","volume":"11","author":"Danielli","year":"2023","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.jpba.2024.116541_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010449","article-title":"Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis","volume":"24","author":"Rochette","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jpba.2024.116541_bib30","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1021\/acs.accounts.2c00497","article-title":"Membrane Association Allosterically Regulates Phospholipase A(2) Enzymes and Their Specificity","volume":"55","author":"Mouchlis","year":"2022","journal-title":"Acc. Chem. Res"},{"key":"10.1016\/j.jpba.2024.116541_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.plipres.2011.02.004","article-title":"Mechanisms of glycerophospholipid homeostasis in mammalian cells","volume":"50","author":"Hermansson","year":"2011","journal-title":"Prog. Lipid Res"},{"key":"10.1016\/j.jpba.2024.116541_bib32","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1742-7843.2007.00066.x","article-title":"Compared effect of immunosuppressive drugs cyclosporine A and rapamycin on cholesterol homeostasis key enzymes CYP27A1 and HMG-CoA reductase","volume":"100","author":"Gueguen","year":"2007","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"10.1016\/j.jpba.2024.116541_bib33","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.2174\/138161211798357926","article-title":"PIP3 regulation as promising targeted therapy of mast-cell-mediated diseases","volume":"17","author":"J. Shenker","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpba.2024.116541_bib34","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524005831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524005831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T07:18:47Z","timestamp":1733037527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524005831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":34,"alternative-id":["S0731708524005831"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116541","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of rapamycin on hepatic metabolomics of non-alcoholic fatty liver rats based on non-targeted platform","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116541"}}